We've done great things in the past.
Today, we're doing great things for the future.
MSD has been pioneering medical progress for more than 125 years. During this time, we have been able to significantly improve treatment of numerous serious and chronic diseases. In the past 50 years alone, MSD has brought 40 new medicines onto the market - many of them representing a new class of active ingredients.
The field of vaccines is part of MSD's history. For over 100 years, we have been developing vaccines that help protect the lives of millions of people. They contribute to the fact that highly infectious diseases, such as rubella, are rare diseases today and certain HPV-related diseases can be prevented.Learn more
The first Swiss subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA was founded in Zurich in 1963. After the global merger between MSD and Schering-Plough in 2009, the Swiss subsidiaries Essex Chemie AG and MSD Switzerland were also merged in 2011. Since that time, the company has had the name MSD Merck Sharp & Dohme AG. The former location of Essex Chemie AG in Lucerne became the headquarters of the merged companies.
Today, MSD employs approximately 71,000 people in over 140 countries (as of 2019) and is one of the world's leading research-based biopharmaceutical companies. In Switzerland, 1000 employees work at four sites in the canton of Lucerne and at one site in Zurich.